To further evaluate whether IL-6 regulates chemotherapy sensitivity in CRC through the modulation of autophagy, we treated cells with IL-6 and chemotherapy drugs in the presence of CQ, a classic inhibitor of autophagy that blocks autophagosome binding to lysosomes by altering the acidic environment of lysosomes. The gene discussed is IL6; the disease is colorectal carcinoma.